Table 1 Characteristics of the study population. All values are given as median [IQR] unless otherwise stated
All (n = 185) | Neurology (n = 59) | Transplantation (n = 66) | Vasculitis and Immunological Disease (n = 32) | Others (n = 28) | One way ANOVA P value | |
|---|---|---|---|---|---|---|
Age (years) | 54.0 [43.0–64.0] | 56.0 [39.0–67.0] | 54.0 [47.0–62.0] | 54.5 [47.3–64.5] | 51.5 [32.5–63.8] | 0.2738 |
Sex (m/f) | 95/90 | 29/30 | 35/31 | 16/16 | 15/13 | NS |
BMI (kg/m2) | 25.5 [22.4–29.3] | 24.8 [21.7–28.2] | 24.3 [22.3–27.8] | 26.1 [22.6–30.6] | 24.7 [22.0–28.4] | 0.1416 |
Hct (%) | 33.9 [29.8–39.2] | 40.2 [37.5–42.9] | 33.7 [31.0–37.0] | 30.5 [27.0–33.6] | 24.6 [20.2–31.2] | < 0.0001 |
PVcalc (ml) | 3240 [2737–3849] | 3058 [2533–3359] | 3194 [2545–3658] | 3984 [3433–4439] | 3699.5 [3125–4149] | < 0.0001 |
PVcalc NADLER (ml) | 3131 [2708–3594] | 2846 [2542–3182] | 3083 [2543–3571] | 3501 [3199–3972] | 3631 [3123–3916] | < 0.0001 |
PVex (ml) | 3500 [3028–3987] | 3599 [3101–4000] | 3600 [3165–4000] | 3443 [3037–3893] | 2998 [2823–3576] | < 0.0001 |
PVex/PVcalc | 1.01 [0.86–1.28] | 1.17 [0.97–1.38] | 1.16 [0.94–1.34] | 0.88 [0.79–0.99] | 0.83 [0.70–0.96] | < 0.0001 |
PV40ml/kg | 3080 [2600–3560] | 3080 [2580–3420] | 2950 [2465–3285] | 3540 [3140–3990] | 3174 [2630–3480] | 0.0004 |
PVcalc/PV40ml/kg (%) | + 4.94% | - 0.72% | + 7.64 | + 11.2% | + 14.21% | p <0.0001 |
PVex/PV40ml/kg (%) | + 12.00% | + 14.42% | + 18.06% | - 2.82% | - 5.91% | p <0.0001 |
Treatments (n) | 5 [3–5] | 5 [5–5] | 4 [3–5] | 5 [3–7] | 4 [2–8] | 0.0078 |
1st - 5th TPE (d) (n= 61) | 7 [6–10] | 7.5 [7–10] | 7 [6–11] | 6.5 [6–7.75] | 4 [4–5.5] | p <0.0001 |
Exchange fluid (%) | ||||||
Albumin | 54.1 | 88.4 | 56.2 | 37.6 | 9.2 | p <0.0001 |
FFP | 34.7 | 7.6 | 22.1 | 45.2 | 87.0 | p <0.0001 |
Mix | 11.2 | 4.0 | 21.7 | 17.2 | 2.7 | p <0-0001 |